based on boron and zinc from readily available, air-stable
B(pin)-substituted alkynes (Scheme 2).7a Thus, regioselec-
tive hydroboration of B(pin)-alkynes generates the 1,1-bis
(boro) intermediates.7a,8 Chemoselective transmetalation
of the more reactive vinyl-BCy2 bond generates 1-alkenyl-
1,1- heterobimetallic reagents. The difference in reactivity
between ZnꢀC vs BꢀC bonds allows for selective reaction
at the ZnꢀC bond with aldehydes to yield B(pin)-substi-
tuted allylic zinc alkoxide intermediates. The alkoxide
intermediates were then employed in various tandem
reactions to form an array of compounds such as B(pin)-
substituted allylic alcohols,7aꢀc R-hydroxy ketones,7a tri-
substituted (E)-allylic alcohols,7a B(pin)-substituted cyclo-
propyl alcohols,7b and B(pin)-substituted allylicacetates.7d
to aldimines activated with a diphenylphosphinoyl moiety
(Scheme 3).13 Carretero14 and co-workers demonstrated
that the reactivity of N-sulfonyl imines could be increased
in the presence of an appropriately positioned heteroaryl
group. Using this strategy, they developedthe alkylationof
aryl N-(2-pyridylsulfonyl) aldimines with organozinc
halides.14b The Carretero and Toru groups both have
utilized the N-pyridylsulfonyl as a novel stereocontrol
element in enantioselective Mannich-type reactions with
silyl enol ethers in the presence of chiral copper catalysts.15
Various related nucleophilic reagents, such as dialkyl
zinc,5,16,17 alkynylzinc,5,18 diethylaluminium cyanide,19
and Danishefsky’s diene,20 have also been investigated in
imine addition reactions to yield the desired amines.
Scheme 2. Generation of 1-Alkenyl-1,1-heterobimetallics of
Boron/Zinc and Additions to Electrophiles
Scheme 3. Wipf’s Vinylation of Aryl Diphenylphosphinoyl
Imines via Vinylzinc Reagents
Our first task in the addition of bimetallics to imines was
to find a suitable imine activating group. The bimetallic
reagent was generated and allowed to react with activated
imines at ꢀ18 °C (Table 1). N-Tosylimines gave a trace
addition product with our alkenyl heterobimetallic re-
agents (entry 1). Rather, a significant amount of reduction
product was isolated. The N-Boc imine behaved similarly,
failing to furnish the desired amine (entry 2). When the
activatinggroupwas changedtodiphenylphosphinoyl, less
than 30% of the allylic amine was isolated. Gratifyingly,
the bimetallic addition to N-pyridyl sulfonyl imine oc-
curred smoothly in 73% yield in toluene at ꢀ18 °C to
furnish the desired product (entry 4). The addition
was then optimized with the N-pyridyl sulfonyl imines.
Switching the solvent from toluene to dicholoromethane
improved the yields slightly (entry 4 vs 7), while, in
THF, almost no product was formed (entry 5). Dimethylzinc
performed better than diethylzinc (entry 7 vs 9). Increasing
the reaction temperature from ꢀ18 to ꢀ10 °C led to a
diminished yield (entry 6 vs 7). With the optimized condi-
tions in entry 7, the scope of the reaction was examined.
Aryl aldimines with electron-donating or -withdrawing
groups were good substrates, providing the B(pin)
Herein, we report the addition of alkenyl-1,1- hetero-
bimetallic reagents to N-(2-pyridylsulfonyl) aldimines to
furnish B(pin)-substituted allylic amines (Scheme 2, lower
part). The addition can be followed by oxidation of the
BꢀC bond to provide R-aminoketones or by Suzuki cross-
coupling to provide densely functionalized trisubstituted
(E)-allylic amines.
Allylic amines9 are important pharmacophores that
can exhibit significant biological properties. Examples
include Acrivastine (Semprex),10 Flunarizine,11 and several
GABA uptake inhibitors.12 As a result, additions to imines
have attracted considerable attention. For example, Wipf
and co-workers reported the addition of vinylzinc reagents
(7) (a) Li, H.; Carroll, P. J.; Walsh, P. J. J. Am. Chem. Soc. 2008, 130,
ꢀ
3521. (b) Hussain, M. M.; Li, H.; Hussain, N.; Urena, M.; Carroll, P. J.;
Walsh, P. J. J. Am. Chem. Soc. 2009, 131, 6516. (c) Hussain, M. M.;
ꢀ
Hernandez-Toribio, J.; Carroll, P. J.; Walsh, P. J. Angew. Chem., Int. Ed.
2011, 50, 6337. (d) Hussain, M. M.; Walsh, P. J. Angew. Chem., Int. Ed.
2010, 49, 1834.
(8) Srebnik, M. Tetrahedron Lett. 1991, 32, 2449.
(9) (a) Kovacic, P. Med. Hypotheses 2007, 69, 1105. (b) Kovacic, P.
Med. Hypotheses 2006, 67, 151.
ꢀ
ꢀ
(15) (a) Gonzalez, A. S.; Arrayas, R. G.; Carretero, J. C. Org. Lett.
2006, 8, 2977. (b) Nakamura, S.; Sano, H.; Nakashima, H.; Kubo, K.;
Shibata, N.; Toru., T. Tetrahedron: Asymmetry 2007, 48, 5565.
(10) (a) Martın, V. S.; Woodward, S. S.; Katsuki, T.; Yamada, Y.;
´
Ikeda, M.; Sharpless, K. B. J. Am. Chem. Soc. 1981, 103, 6237. (b) Slater,
J. W.; Zechnich, A. D.; Haxby, D. G. Drugs 1999, 57, 31.
(11) (a) Straub, H.; Koehling, R.; Speckmann, E. J. Brain Res. 1994,
658, 119. (b) Ashton, D.; Reid, K.; Willems, R.; Marrannes, R.;
Wauguier, A. Drug Develop. Res. 1986, 8, 396.
(12) Gibson, J. R.; Manna, V. K.; Salisbury, J. J. Int. Med. Res. 1989,
17, 28.
(13) Wipf, P.; Kendall, C.; Stephenson, C. R. J. J. Am. Chem. Soc.
2003, 125, 761.
^ ꢀ
(16) Charette, A. B.; Boezio, A. A.; Cote, A.; Moreau, E.; Pytkowicz,
J.; Desrosiers, J. -N.; Legault, C. Pure Appl. Chem. 2005, 77, 1259.
(17) Porter, J. R.; Traverse, J. F.; Hoveyda, A. H.; Snapper, M. L.
J. Am. Chem. Soc. 2001, 123, 984.
(18) Zani, L.; Alesi, S.; Cozzi, P. G.; Bolm, C. J. Org. Chem. 2006, 71,
1558.
(19) Nakamaru, S.; Sato, N.; Sugimoto, M.; Toru, T. Tetrahedron:
Asymmetry 2004, 15, 1513.
ꢀ
(14) (a) Esquivias, J.; Arrayas, R. G.; Carretero, J. C. J. Org. Chem.
ꢀ
ꢀ
ꢀ
ꢀ
(20) Mancheno, O. G.; Gonzalez, A. S.; Arrayas, R. G.; Carretero,
2005, 70, 7451. (b) Esquivias, J.; Arrayas, R. G.; Carretero, J. C. Angew.
Chem., Int. Ed. 2006, 45, 629.
J. C. J. Am. Chem. Soc. 2004, 126, 456.
Org. Lett., Vol. 13, No. 24, 2011
6465